Compare J.B.Chemicals with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AUROBINDO PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AUROBINDO PHARMA J.B.CHEMICALS/
AUROBINDO PHARMA
 
P/E (TTM) x 38.0 17.1 221.8% View Chart
P/BV x 7.1 3.7 190.6% View Chart
Dividend Yield % 0.2 0.3 58.6%  

Financials

 J.B.CHEMICALS   AUROBINDO PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
AUROBINDO PHARMA
Mar-19
J.B.CHEMICALS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs363830 43.7%   
Low Rs255527 48.4%   
Sales per share (Unadj.) Rs169.1333.9 50.7%  
Earnings per share (Unadj.) Rs16.640.4 41.1%  
Cash flow per share (Unadj.) Rs23.451.8 45.2%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Dividend yield (eoy) %0.60.4 175.6%  
Book value per share (Unadj.) Rs172.5237.1 72.8%  
Shares outstanding (eoy) m83.57585.91 14.3%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.82.0 89.9%   
Avg P/E ratio x18.616.8 110.7%  
P/CF ratio (eoy) x13.213.1 100.7%  
Price / Book Value ratio x1.82.9 62.6%  
Dividend payout %12.06.2 194.5%   
Avg Mkt Cap Rs m25,827397,569 6.5%   
No. of employees `0003.817.9 21.1%   
Total wages/salary Rs m2,51125,849 9.7%   
Avg. sales/employee Rs Th3,747.410,956.9 34.2%   
Avg. wages/employee Rs Th665.71,447.7 46.0%   
Avg. net profit/employee Rs Th367.81,324.3 27.8%   
INCOME DATA
Net Sales Rs m14,135195,636 7.2%  
Other income Rs m3661,553 23.6%   
Total revenues Rs m14,501197,189 7.4%   
Gross profit Rs m2,17839,519 5.5%  
Depreciation Rs m5706,680 8.5%   
Interest Rs m352,626 1.3%   
Profit before tax Rs m1,94031,767 6.1%   
Minority Interest Rs m027 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-881 0.0%   
Tax Rs m5527,269 7.6%   
Profit after tax Rs m1,38723,645 5.9%  
Gross profit margin %15.420.2 76.3%  
Effective tax rate %28.522.9 124.5%   
Net profit margin %9.812.1 81.2%  
BALANCE SHEET DATA
Current assets Rs m10,470153,645 6.8%   
Current liabilities Rs m2,749120,429 2.3%   
Net working cap to sales %54.617.0 321.7%  
Current ratio x3.81.3 298.5%  
Inventory Days Days55135 40.8%  
Debtors Days Days7864 121.9%  
Net fixed assets Rs m5,811103,909 5.6%   
Share capital Rs m167586 28.5%   
"Free" reserves Rs m14,248138,322 10.3%   
Net worth Rs m14,416138,908 10.4%   
Long term debt Rs m01,800 0.0%   
Total assets Rs m17,649264,544 6.7%  
Interest coverage x56.613.1 431.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.7 108.3%   
Return on assets %8.19.9 81.1%  
Return on equity %9.617.0 56.5%  
Return on capital %13.723.8 57.5%  
Exports to sales %049.6 0.0%   
Imports to sales %018.8 0.0%   
Exports (fob) Rs mNA97,091 0.0%   
Imports (cif) Rs mNA36,741 0.0%   
Fx inflow Rs m6,16497,316 6.3%   
Fx outflow Rs m1,33440,589 3.3%   
Net fx Rs m4,82956,727 8.5%   
CASH FLOW
From Operations Rs m1,23116,220 7.6%  
From Investments Rs m-208-28,768 0.7%  
From Financial Activity Rs m-59519,191 -3.1%  
Net Cashflow Rs m4276,656 6.4%  

Share Holding

Indian Promoters % 55.4 54.1 102.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 8.0 42.6%  
FIIs % 3.9 27.7 14.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.2 362.7%  
Shareholders   30,437 69,601 43.7%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Surged 1,147 Points Today(Closing)

Indian share markets continued their momentum and ended their day on a strong note today.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Mar 3, 2021 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS